Development of Potent PfCLK3 Inhibitors Based on TCMDC-135051 as a New Class of Antimalarials

[Image: see text] The protein kinase PfCLK3 plays a critical role in the regulation of malarial parasite RNA splicing and is essential for the survival of blood stage Plasmodium falciparum. We recently validated PfCLK3 as a drug target in malaria that offers prophylactic, transmission blocking, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahindra, Amit, Janha, Omar, Mapesa, Kopano, Sanchez-Azqueta, Ana, Alam, Mahmood M., Amambua-Ngwa, Alfred, Nwakanma, Davis C., Tobin, Andrew B., Jamieson, Andrew G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497403/
https://www.ncbi.nlm.nih.gov/pubmed/32787140
http://dx.doi.org/10.1021/acs.jmedchem.0c00451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497403/
https://www.ncbi.nlm.nih.gov/pubmed/32787140
http://dx.doi.org/10.1021/acs.jmedchem.0c00451

Ejemplares similares